Ivana Gojo
Ivana Gojo publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Hematopoietic Stem Cell Transplantation.
- World rank
- #223,139 of 7,710,434 ranked researchers
- Rank in United States
- #82,512 of 1,627,098
- Works
- 272
- Citations
- 9.7k
- Citations per work
- 35.8
What does Ivana Gojo research?
Ivana Gojo's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16761.5%
- Medicine16761.5%
- Life Sciences6423.6%
- Everything else4114.9%
- 1Hematology36% of their works
- 2Molecular Biology18% of their works
- 3Oncology13% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5Genetics6% of their works
- 6Immunology6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Histone Deacetylase Inhibitors Research
- CAR-T cell therapy research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
Which keywords describe Ivana Gojo's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Minimal Residual Disease, Acute Lymphoblastic Leukemia, Childhood Cancer and Bone Marrow Niche.
- Diagnosis Criteria
- JAK2 Mutation
- CAR T Cells
- HDAC Inhibitors
- BCR-ABL
- Bone Marrow Niche
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Minimal Residual Disease
- Childhood Cancer
- Graft-versus-Host Disease
- Imatinib
- Histone Deacetylases
- Chimeric Antigen Receptor
- Myelofibrosis
- International Myeloma Working Group
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors1992 topics
- Hematopoietic Stem Cells1922 topics
- AML1521 topic
- Acute Myeloid Leukemia1521 topic
- Minimal Residual Disease692 topics
- Acute Lymphoblastic Leukemia471 topic
- Childhood Cancer471 topic
- Bone Marrow Niche401 topic
- Graft-versus-Host Disease401 topic
- BCR-ABL391 topic
- Imatinib391 topic
- HDAC Inhibitors341 topic
- Histone Deacetylases341 topic
- CAR T Cells301 topic
- Chimeric Antigen Receptor301 topic
- JAK2 Mutation241 topic
- Myelofibrosis241 topic
- Diagnosis Criteria221 topic
- International Myeloma Working Group221 topic
Where does Ivana Gojo work?
Ivana Gojo's main affiliation in the publication record is Sidney Kimmel Comprehensive Cancer Center, United States.
How many publications and citations does Ivana Gojo have?
OpenAlex counts 272 works and 9,730 citations for Ivana Gojo, an h-index of 53, ranking #223,139 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ivana Gojo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.